title: Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions.
abstract: Ketoconazole and rifampin are the most widely used compounds examined in recent drug-drug interaction (DDI) studies, and they have multiple roles in modulating drug metabolizing enzymes and transporters. To determine the underlying mechanisms of DDI, this study was performed to investigate the inhibitory effects of ketoconazole and rifampin on the functions of OAT1 and OATP1B1, and to evaluate the potential of ketoconazole and rifampin for DDI with substrate drugs for these transporters in a clinical setting. Ketoconazole inhibited OATP1B1-mediated transport activity, while rifampin inhibited OAT1 and OATP1B1. Inhibition by rifampin and ketoconazole of the uptake of olmesartan, a substrate for OAT1 and OATP1B1, was evaluated in oocytes overexpressing these transporters. The K(i) values for rifampin on OAT1 and OATP1B1-mediated olmesartan uptake were 62.2 and 4.42 µM, respectively, and the K(i) value for ketoconazole on OATP1B1-mediated olmesartan uptake was 66.1 µM. As measured plasma concentrations of rifampin and ketoconazole were 7.29 and 6.4-13.3 µM, respectively, the likelihood of an OATP1B1-mediated drug-drug interaction between rifampin and olmesartan is thought to be possible, whereas OAT1 or OATP1B1-mediated DDI between rifampin or ketoconazole and olmesartan appears unlikely in the clinical setting.
authors: Department of Pharmaceutics, College of Pharmacy, Dankook University, Cheonan, Korea.
authors: Min-Koo
authors: MK
authors: Choi
authors: Qing-Ri
authors: QR
authors: Jin
authors: Yeong-Lim
authors: YL
authors: Choi
authors: Sung-Hoon
authors: SH
authors: Ahn
authors: Myung-Ae
authors: MA
authors: Bae
authors: Im-Sook
authors: IS
authors: Song
mesh_terms: D000818:Animals; D000904:Antibiotics, Antitubercular / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects; D004347:Drug Interactions; D007093:Imidazoles / Q000378:metabolism*; D007654:Ketoconazole / Q000494:pharmacology*; D027381:Liver-Specific Organic Anion Transporter 1; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D027362:Organic Anion Transport Protein 1 / Q000037:antagonists & inhibitors*; D027361:Organic Anion Transporters / Q000037:antagonists & inhibitors*; D012293:Rifampin / Q000494:pharmacology*; D013777:Tetrazoles / Q000378:metabolism*; D014982:Xenopus laevis
chemical_list: D000904:Antibiotics, Antitubercular; D000935:Antifungal Agents; D007093:Imidazoles; D027381:Liver-Specific Organic Anion Transporter 1; D027362:Organic Anion Transport Protein 1; D027361:Organic Anion Transporters; C503999:SLCO1B1 protein, human; D013777:Tetrazoles; C437965:olmesartan; D007654:Ketoconazole; D012293:Rifampin